Sponsor:
Adrienne G. Waks
Code:
NCT06100874
Conditions
Her 2 Positive Breast Cancer
Breast Cancer Female
Breast Cancer Metastatic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Govitecan
Trastuzumab
Trastuzumab and Hyaluronidase-oysk
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Adrienne G. Waks on 2025-02-28.